Intra-Cellular Therapies (ITCI) 10-Q2015 Q2 Quarterly report

Filed: 5 Aug 15, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: accurate, adhere, adherence, adjunctive, administer, advantage, affiliated, attention, attest, attestation, auditor, billed, block, bring, build, calendar, capacity, cGMP, civil, COBRA, compete, comply, complying, composition, compromised, confidence, Counsel, coupled, criminal, customary, damage, death, defending, defense, disability, disposition, disruption, divert, easy, efficient, eliminate, employment, encounter, enforced, enforcement, enforcing, entail, estate, European, experienced, expertise, face, fail, FDIC, filer, firm, force, foreign, fully, Global, Halstead, harm, harmed, implement, implementation, impose, imposed, incrementally, indemnification, independent, independently, interim, interruption, investor, jeopardized, knowledge, larger, launch, lawsuit, liable, listed, listing, lithium, lose, lost, lot, lump, managerial, monotherapy, multicenter, mutual, NASDAQ, ordinary, OTC, OTCQB, packaging, permitted, preceding, preliminary, premarket, prematurely, premium, prepaid, prevailing, prioritization, pro, profitable, proper, prosecuting, prosecution, proxy, rata, reach, recruit, recruiting, release, rely, renew, renewed, rent, reposition, reproducibility, reputation, Secretary, size, stability, strictly, suffer, suitable, sum, suspension, technical, therapy, training, travel, Turmoil, turn, Union, unnecessarily, unqualified, unrelated, untaken, unvested, vacation, valproate, variation, Vice, volume, wide, withdrawal

Removed: absence, Administration, finalizing, Food, Guide, overlap, randomize

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ITCI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATIONS UNDER SECTION 906

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Intra-Cellular Therapies, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report for the quarter ended June 30, 2015 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: August 5, 2015				/s/ Sharon Mates, Ph.D.
				Sharon Mates, Ph.D.
				Chairman, President and Chief Executive Officer
				(principal executive officer)

Dated: August 5, 2015				/s/ Lawrence J. Hineline
				Lawrence J. Hineline
				Vice President of Finance and Chief Financial Officer (principal financial officer)